Publications by authors named "J Lopez-Bastida"
Article Synopsis
- - The study analyzes the economic burden and health-related quality of life (HRQoL) of epidermolysis bullosa (EB) patients in Spain, highlighting the financial impact on both patients and society.
- - With an average annual cost of €31,352 per patient, the costs consist mainly of non-healthcare expenses (71.3%), healthcare costs (17.2%), and productivity losses (11.5%).
- - HRQoL scores indicate a significant impact, with severe EB patients scoring lower (0.45) than non-severe situations (0.62), underlining the importance of considering both direct and indirect costs in healthcare policies.
Background: The Tenosynovial giant cell tumor Observational Platform Project (TOPP) registry is an international prospective study that -previously described the impact of diffuse-type tenosynovial giant cell tumour (D-TGCT) on patient-reported outcomes (PROs) from a baseline snapshot. This analysis describes the impact of D-TGCT at 2-year follow-up based on treatment strategies.
Material And Methods: TOPP was conducted at 12 sites (EU: 10; US: 2).
Background And Objectives: Diffuse-tenosynovial giant cell tumor (D-TGCT) is a rare, locally aggressive, typically benign neoplasm affecting mainly large joints, representing a wide clinical spectrum. We provide a picture of the treatment journey of D-TGCT patients as a 2-year observational follow-up.
Methods: The TGCT Observational Platform Project registry was a multinational, multicenter, prospective observational study at tertiary sarcoma centers spanning seven European countries and two US sites.
Background: Multiple sclerosis imposes a heavy burden on the person who suffers from it and on the relatives, due to the caregiving load involved. The objective was to analyse whether the inclusion of social costs in economic evaluations of multiple sclerosis-related interventions changed results and/or conclusions.
Methods: A systematic review was launched using Medline and the Cost-Effectiveness Analysis Registry of Tufts University (2000-2019).
Background: Tenosynovial Giant-Cell Tumour (TGCT) is a benign clonal neoplastic proliferation arising from the synovium, causing a variety of symptoms and often requiring repetitive surgery. This study aims to define the economic burden-from a societal perspective-associated with TGCT patients and their health-related quality of life (HRQOL) in six European countries.
Methods: This article analyses data from a multinational, multicentre, prospective observational registry, the TGCT Observational Platform Project (TOPP), involving hospitals and tertiary sarcoma centres from six European countries (Austria, France, Germany, Italy, the Netherlands, and Spain).